XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues $ 690.3 $ 648.9 $ 2,034.4 $ 1,989.6
Cost of revenues 424.1 409.2 1,263.3 1,219.4
Gross profit 266.2 239.7 771.1 770.2
Selling, general and administrative expenses 215.6 279.4 676.5 695.2
Divestiture losses, net 0.0 10.9 0.0 10.9
Income (loss) from operations 50.6 (50.6) 94.6 64.1
Interest expense, net (19.8) (18.8) (54.6) (55.1)
Other income, net 2.3 0.5 0.8 0.5
Income (loss) before income taxes 33.1 (68.9) 40.8 9.5
Income tax (expense) benefit (5.1) 3.0 (16.4) (19.9)
Net income (loss) 28.0 (65.9) 24.4 (10.4)
Net income attributable to noncontrolling interests 0.0 (0.1) (0.2) (0.2)
Net income (loss) attributable to Stericycle, Inc. common shareholders $ 28.0 $ (66.0) $ 24.2 $ (10.6)
Earnings (loss) per common share attributable to Stericycle, Inc. common shareholders        
Basic (in dollars per share) $ 0.30 $ (0.72) $ 0.26 $ (0.11)
Diluted (in dollars per share) $ 0.30 $ (0.72) $ 0.26 $ (0.11)
Weighted average number of common shares outstanding:        
Basic (in shares) 92.2 91.9 92.1 91.8
Diluted (in shares) 92.4 91.9 92.4 91.8